Related Experiment Video
Updated: Nov 1, 2025

Preparation and Culture of Rat Lens Epithelial Explants for Studying Terminal Differentiation
Published on: September 22, 2009
Transforming growth factor-β2-mediated mesenchymal transition in lens epithelial cells is repressed in the absence of
Mi-Hyun Nam1, Mina B Pantcheva1, Johanna Rankenberg1
1Sue Anschutz-Rodgers Eye Center and Department of Ophthalmology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, U.S.A.
Abstract:
Transforming growth factor-β2 (TGFβ2)-mediated epithelial to mesenchymal transition (EMT) in lens epithelial cells (LECs) has been implicated in fibrosis associated with secondary cataracts. In this study, we investigated whether the receptor for advanced glycation end products (RAGE) plays a role in TGFβ2-mediated EMT in LECs. Unlike in the LECs from wild-type mice, TGFβ2 failed to elicit an EMT response in LECs from RAGE knockout mice. The lack of RAGE also diminished TGFβ2-mediated Smad signaling. In addition, treatment with TGFβ2 increased IL-6 levels in LECs from wild-type mice but not in those from RAGE knockout mice. Treatment of human LECs with the RAGE inhibitor FPS-ZM1 reduced TGFβ2-mediated Smad signaling and the EMT response. Unlike that in wild-type lenses, the removal of fiber cell tissue in RAGE knockout lenses did not result in elevated levels of α-smooth muscle actin (α-SMA), fibronectin (FN), and integrin β1 in capsule-adherent LECs. Taken together, these results suggest that TGFβ2 signaling is intricately linked to RAGE. Targeting RAGE could be explored as a therapeutic strategy against secondary cataracts.
Insights
The receptor for advanced glycation end products (RAGE) is crucial for transforming growth factor-β2 (TGFβ2)-induced epithelial to mesenchymal transition (EMT) in lens epithelial cells. Targeting RAGE may offer a new therapeutic approach for secondary cataracts.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Secondary cataracts are often associated with fibrosis driven by transforming growth factor-β2 (TGFβ2)-induced epithelial to mesenchymal transition (EMT) in lens epithelial cells (LECs).
- The role of the receptor for advanced glycation end products (RAGE) in this process remains unclear.
Purpose of the Study:
- To investigate the involvement of RAGE in TGFβ2-mediated EMT in LECs.
- To explore RAGE as a potential therapeutic target for secondary cataracts.
Main Methods:
- Utilized RAGE knockout mice and wild-type mice for comparative studies of LECs.
- Administered TGFβ2 to LECs and analyzed EMT markers, Smad signaling, and IL-6 levels.
- Treated human LECs with a RAGE inhibitor (FPS-ZM1) and assessed TGFβ2-induced responses.
- Examined α-smooth muscle actin (α-SMA), fibronectin (FN), and integrin β1 expression in mouse lenses.
Main Results:
- TGFβ2 failed to induce EMT in LECs from RAGE knockout mice, unlike in wild-type mice.
- RAGE deficiency attenuated TGFβ2-mediated Smad signaling and IL-6 production in LECs.
- Inhibition of RAGE in human LECs reduced TGFβ2-induced Smad signaling and EMT.
- RAGE knockout lenses showed no elevation of α-SMA, FN, and integrin β1 after fiber cell removal, unlike wild-type lenses.
Conclusions:
- TGFβ2-mediated EMT in LECs is dependent on RAGE signaling.
- RAGE plays a significant role in the fibrotic processes associated with secondary cataracts.
- Targeting RAGE presents a promising therapeutic strategy for preventing or treating secondary cataracts.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
The Ras Gene
Ras is a...
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

